Vonoprazan

Phathom Pharmaceuticals, Erosive GERD, Vonoprazan, Complete Response Letter, Gastroesophageal reflux disease

Phathom Pharmaceuticals Boosts Erosive GERD Application with Six-Month Stability Data Submission for Vonoprazan

Anika Sharma

Phathom Pharmaceuticals, a pioneering biopharmaceutical company dedicated to groundbreaking solutions for gastrointestinal ailments, has announced a significant stride in its ...